Author

Mirari Marques

Spanish National Cancer Research Centre

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Francisco X. RealiD· 2 shared Jaime Martínez de VillarrealiD· 2 shared Ana CuadradoiD· 1 shared Catalina Berca· 1 shared Direna Alonso‐CurbeloiD· 1 shared Eduardo CaleirasiD· 1 shared Elena AndradaiD· 1 shared Enrique Carrillo de Santa PauiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Francisco X. RealORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GATA4 loss promotes mutant Kras-driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions

Francesc Madriles, Mónica P. de Andrés, Mikhail Chesnokov, Jaime Martínez de Villarreal, Direna Alonso‐Curbelo, Natalia del Pozo, Mar Iglesias, Enrique Carrillo de Santa Pau, Juan Iovanna, Francisco Soriano, Ana Cuadrado, Mirari Marques, Javier Muñoz, Irene Esposito, Paola Martinelli, , Francisco X. Real

This study shows that GATA4 loss in Kras-mutant mice leads to PDAC without canonical precursor lesions, identifying a new lesion type and revealing GATA4's role in inflammatory programs.

bioRxiv · May 26, 2026 · PreprintCancer Biology

Nerve growth factor receptor identifies a basal subpopulation linked to poor prognosis and reduced immunotherapy responses in bladder cancer

Juan García-Agulló, Vanesa Santos, Mark Kalisz, Mirari Marques, Elena Andrada, Catalina Berca, Maria Ramal, Jaime Martínez de Villarreal, Manuel Pérez‐Martínez, Markus Eckstein, Raquel Benítez, Eduardo Caleiras, Núria Malats, Francisco X. Real, Héctor Peinado

This study identifies NGFR as a marker of a basal BLCA subpopulation associated with poor prognosis and reduced immunotherapy response.

bioRxiv · May 18, 2026 · PreprintCancer Biology